Cargando…

A Unique Urinary Metabolic Feature for the Determination of Bladder Cancer, Prostate Cancer, and Renal Cell Carcinoma

Prostate cancer (PCa), bladder cancer (BCa), and renal cell carcinoma (RCC) are the most prevalent cancer among urological cancers. However, there are no cancer-specific symptoms that can differentiate them as well as early clinical signs of urological malignancy. Furthermore, many metabolic studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sujin, Ku, Ja Yoon, Kang, Byeong Jin, Kim, Kyung Hwan, Ha, Hong Koo, Kim, Suhkmann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468099/ https://www.ncbi.nlm.nih.gov/pubmed/34564407 http://dx.doi.org/10.3390/metabo11090591

Ejemplares similares

Urinary Markers for Bladder Cancer Diagnosis and Monitoring
por: Jeong, Seung-Hwan, et al.
Publicado: (2022)

Comparative Analysis of Proteomes and Phosphoproteomes in Patients with Prostate Cancer Using Different Surgical Conditions
por: Ahn, Hee-Sung, et al.
Publicado: (2022)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers
por: Choi, Ji Soo, et al.
Publicado: (2017)

Long-term oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer: Systemic review and meta-analysis of 5-year and 10-year follow-up data
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers
por: Krengli, Marco, et al.
Publicado: (2017)

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer
por: Yun, Seok Joong, et al.
Publicado: (2017)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Can microfocal prostate cancer be regarded as low-risk prostate cancer?
por: Lee, Seung Hwan, et al.
Publicado: (2013)

Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Lymphoepithelioma-like Carcinoma of the Urinary Bladder
por: Yun, Han Ki, et al.
Publicado: (2010)

Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer
por: Park, Vivian Youngjean, et al.
Publicado: (2016)

SAT-LB306 A Case of Synchronous Non-Functioning Paraganglioma of the Urinary Bladder and Prostate Cancer
por: Choi, Moon Kyung, et al.
Publicado: (2020)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

Effect of Photoselective Vaporization Prostatectomy on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia With or Without Intravesical Prostatic Protrusion
por: Kim, Myung Soo, et al.
Publicado: (2013)

Upper and lower urinary tract obstruction secondary to inguinoscrotal hernia containing bladder and prostate gland
por: Dawson, Jonathon, et al.
Publicado: (2021)

Lower Urinary Tract Symptoms With a View Beyond the Bladder and Prostate
por: Kim, Su Jin
Publicado: (2022)

Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers
por: Tyagi, Heena, et al.
Publicado: (2021)

Functions of circular RNAs in bladder, prostate and renal cell cancer
por: Yang, Longfei, et al.
Publicado: (2021)

Malignant Inflammatory Myofibroblastic Tumor of the Bladder with Rapid Progression
por: Kim, Hyeon Woo, et al.
Publicado: (2012)

Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
por: Kim, Byung Soo, et al.
Publicado: (2018)

Urinary markers for bladder cancer
por: Smith, Zachary L., et al.
Publicado: (2013)

The Urinary Microbiome and Bladder Cancer
por: Heidar, Nassib Abou, et al.
Publicado: (2023)

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
por: Jin, Xing, et al.
Publicado: (2014)

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2016)

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Review of non-invasive urinary biomarkers in bladder cancer
por: Lee, Hyung-Ho, et al.
Publicado: (2020)

Clinical factors that influence the occurrence of symptomatic pseudoaneurysms and arteriovenous fistulas after partial nephrectomy: multi-institutional study of renal function outcomes after one year of selective arterial embolization
por: Lee, Chan Ho, et al.
Publicado: (2020)

Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
por: Lee, Seung Hwan, et al.
Publicado: (2011)

Corrigendum: Acknowledgments. Effect of Photoselective Vaporization Prostatectomy on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia With or Without Intravesical Prostatic Protrusion
por: Kim, Myung Soo, et al.
Publicado: (2013)

Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2016)

Where are we now and where are we heading in muscle invasive bladder cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2020)

Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication
por: Kim, Min Hwan, et al.
Publicado: (2015)

Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer
por: Jin, Di, et al.
Publicado: (2020)

Metastatic renal cell carcinoma in the thyroid gland: ultrasonographic features and the diagnostic role of core needle biopsy
por: Song, Ok Kyu, et al.
Publicado: (2017)

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
por: Tae, Bum Sik, et al.
Publicado: (2017)

Granular Cell Tumor of the Urinary Bladder
por: Kang, Ho-Won, et al.
Publicado: (2010)

Combined Treatment with Anticancer Vaccine Using Genetically Modified Endothelial Cells and Imatinib in Bladder Cancer
por: Ha, Seung Beom, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ntc3k6a65nesobbi7eaumcbo55